# TAP Versus Thoracic Epidural in Major Abdominal Resections

> **NCT02197988** · NA · COMPLETED · sponsor: **Corewell Health West** · enrollment: 75 (actual)

## Conditions studied

- Malignant Neoplasm of Abdomen
- Surgery

## Interventions

- **DRUG:** Exparel 1.33% (20ml Volume)
- **DRUG:** 0.125% bupivicaine with 2 mcg/ml Fentanyl.

## Key facts

- **NCT ID:** NCT02197988
- **Lead sponsor:** Corewell Health West
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-03
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02197988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02197988, "TAP Versus Thoracic Epidural in Major Abdominal Resections". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02197988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*